Eagle Bags Vasopressin Exclusivity And Details Launch Plans
US Agency Also Dishes Out Tentative Nod For Amphastar’s’ ANDA Product
Generic competition to Vasostrict is nearing in the US after the FDA confirmed Eagle’s previously unresolved potential for 180-day market exclusivity.
